Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, Tolerability, PK and PD of ONO-7684 in Healthy Subjects
NCT03919890Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jan 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ONO-7684 in venous thromboembolism (VTE) (6 arms), sponsored by Ono Pharmaceutical. Primary endpoints: Number of participants with clinically significant changes in vital signs, Number of participants with clinically significant changes observed on 12-lead electrocardiogram (ECG) and 4 more. Started Jan 2019; status: completed.
02
Drugs
ONO-7684
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03919890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03919890.